Family Medicine Doctors in O Fallon, MO Accepting Medicare

30 Family Medicine doctors found. Showing 21 - 30

Daniel Martin Weisel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy Ste 108, O Fallon, MO 63368 Phone: 636-344-2400

Dr. Jyoti G Kulkarni, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2630 Highway K, O Fallon, MO 63368 Phone: 636-240-5454    Fax: 636-980-5335

Nelson G Usry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5551 Winghaven Blvd, Ste 142, O Fallon, MO 63368 Phone: 636-695-2510    Fax: 636-695-2512

Dr. Heather Carolyn Williamson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3449 Pheasant Meadow Dr, Ste 107, O Fallon, MO 63368 Phone: 636-379-4140    Fax: 636-379-4132

Sean A Mcintosh, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy, Ste 108, O Fallon, MO 63368 Phone: 636-344-2400    Fax: 636-344-2401

Devin Bell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy Ste 108, O Fallon, MO 63368 Phone: 636-344-2400    Fax: 636-344-2401

Chris Feightner Blanner, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Winding Woods Dr, Suite 222, O Fallon, MO 63366 Phone: 636-978-8600

Caitlin Sue Rogers, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Progress Point Pkwy Ste 108, O Fallon, MO 63368 Phone: 636-344-2400    Fax: 636-344-2401

Dr. Wan In L Koo, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Highway K, O Fallon, MO 63366 Phone: 636-379-8138    Fax: 636-669-2401

Dr. Jackson Charles Pugh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Winding Woods Dr Ste 100, O Fallon, MO 63366 Phone: 636-379-4329

News Archive

FDA to review Acorda Therapeutics' NDA for Fampridine-SR

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company's New Drug Application (NDA) for Fampridine-SR on October 14, 2009.

Repros Therapeutics receives positive feedback from FDA for Androxal

Repros Therapeutics Inc. today announced that the Company has received positive written feedback from the FDA (the "Agency") regarding the Company's drug candidate Androxal. The Agency concurred with Repros' indication statement for the use of Androxal in the treatment of secondary hypogonadism in men wishing to preserve fertility.

Special bioactive scaffolds lead to greater functional recovery from spinal cord injury in mice

In mice with a spinal cord injury, mixing materials including bioactive sequences formed a polymer meshwork that improved axon regrowth, angiogenesis, and neuronal cell survival.

Study finds life expectacy in large portions of U.S. are stagnating or declining

"Large swaths of the United States are showing decreasing or stagnating life expectancy even as the nation's overall longevity trend has continued upwards, according to a county-by-county study of life expectancy over two decades," researchers at the Institute of Health Metrics and Evaluation (IHME) at the University of Washington note in the journal Population Health Metrics, the Washington Post reports (Brown, 6/15).

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)